https://www.selleckchem.com/products/amg-232.html
Studies in low-income countries have shown that among Bacille Calmette-Guérin (BCG) vaccinated children, those who develop a BCG-scar have significantly better survival than those who do not develop a scar. In a Danish multicenter randomized clinical trial we assessed determinants for developing a BCG-scar and for BCG scar size following neonatal BCG vaccination. At three Danish hospitals, newborns were randomized 11 to BCG vaccination or no BCG vaccination. The infants were invited for a clinical examination at the ages of 3 and 13 mon
Curtir
Comentario
Compartilhar
